Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong revenue growth quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.
Scott Willis
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 13th, 2019)
A weekly review of the most important marijuana stock news to impact your portfolio. From legalization developments to acquisitions, we have you covered.
Canadian Cannabis Scorecard (Spring 2019)
Confused about which marijuana stocks are worth your money? The cannabis scorecard is your guide to separating the best from the worst.
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 6th, 2019)
A weekly review of only the most important cannabis news to impact your portfolio....
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 30th, 2019)
A weekly review of only the most important cannabis news to impact your portfolio...
Lyft Stock Guide – Transportation Disruptor or Money Pit?
With Lyft kicking off the ride-sharing IPO battle against Uber, we've delved into the ride-hailing business model and potential profitability for the stock.
Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis
In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with operations. Impressive.
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 23rd, 2019)
A weekly review of only the most important cannabis news to impact your portfolio, including Curaleaf earnings, California marijuana supply and more.
Tilray Q4 2018 Earnings – Eye Watering Stock Price Hard to Justify
Tilray's first quarter with recreational sales failed to impress. Question marks remain how the company will grow into...